SCHEMBL4154916

SCHEMBL4154916

NNc1ccc(CC(=O)O)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.59
MAPT P10636 4/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
GAA P10253 2/20 0.46
RGS12 O14924 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46
THPO P40225 1/20 0.46
BLM P54132 1/20 0.46
GNAI1 P63096 1/20 0.46
PMP22 Q01453 1/20 0.46
HIF1A Q16665 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 3/20 0.45
CA1 P00915 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13874195 0.82 ALDH1A1 (0.53) CA2MAPTHPGDGAALMNA
SCHEMBL1930501 0.81 CA2 (0.57) CA2MAPTKDM4EHPGDHSD17B10
SCHEMBL29014047 0.80 CA2 (0.56) CA2MAPTKDM4EHPGDHSD17B10
SCHEMBL1285674 0.80 CA2 (0.56) CA2MAPTKDM4EHPGDHSD17B10
SCHEMBL11486873 0.79 KDM4E (0.46) CA2MAPTKDM4EHPGDHSD17B10
SCHEMBL11488993 0.79 MAPT (0.48) MAPTHPGDHSD17B10LMNAPOLB
SCHEMBL3274390 0.78 CA1 (0.46) CA2MAPTHPGDHSD17B10LMNA
SCHEMBL283587 0.77 CA2 (0.71) CA2MAPTKDM4EHPGDHSD17B10
SCHEMBL11492509 0.77 CA2 (0.50) CA2MAPTKDM4EHPGDHSD17B10
SCHEMBL2597844 0.77 CA2 (0.65) CA2MAPTKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090093474-A1 THIAZOLYL-DIHYDRO-INDAZOLE GRAUERT MATTHIAS 2009-04-09 US disclosed
US-20070238718-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed
US-4239901-A ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1980-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093474-A1 THIAZOLYL-DIHYDRO-INDAZOLE CYP3A43, CYP3A5, UGT1A3 CA2 887/4885MAPT 37/4885KDM4E 4765/4885
US-20070238718-A1 THIAZOLYL-DIHYDRO-INDAZOLE CYP3A43, CYP3A5, UGT1A3 CA2 887/4885MAPT 37/4885KDM4E 4765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.